当前位置: 首页 > 期刊 > 《世界中医药》 > 201712
编号:13611515
银杏达莫联合醒脑静治疗脑出血患者疗效及对外周血S100B、神经肽Y水平的影响(3)
http://www.100md.com 2017年6月15日 《世界中医药》 201712
     [4]Michalkiewicz M,Zhao G,Jia Z,et al.Central neuropeptideY signaling ameliorates N(omega)-nitro-L-arginine methyl esterhypertension in the rat through a Y1 receptor mechanism[J].Hypertension,2005,45(4):780-785.

    [5]孙巨军,张鹏,杨三林.脑出血患者血浆神经肽Y的检测及意义[J].陕西医学杂志,2007,36(10):1473-1475.

    [6]Chen Q M.The pharmacological basis and clinical application ofXingnaojing Injection[J].Chin J Integr Trad West Med Crit Care,1999,6(4):191-192.

    [7]Tu Y,Yang X P,Shang C Z.Protective effect of Xingnaojinginjection on traumatic brain injury[J].Chin J Appl Physiol,2014,30(3):230-232.

    [8]张应会,郭霞,丁毅,等.银杏达莫注射液对高血压脑出血神经功能恢复的影响[J].中国实验方剂学杂志,2015,21(11):194-197.

    [9]管静静,赵冠安,张学磊,等.银杏达莫注射液用于高血压脑出血微创术后神经功能恢复的临床观察[J].中国药房,2015,26(32):4526-4528.

    [10]Chinese Society of Neurology.Guidelines for diagnosis and treatmentof intracerebral hemorrhage in China(2014)[J].Chin J Neurol,2015,48(6):435-444.

    [11]Gao W Y.The change and its significance of serum myocardialzymogram level in patients with acute cerebral hemorrhage by NIHSSand MMSE[J].Chin J Practical Nervous Dis,2014,17(23):90-91.

    [12]郭富強,扬友松,宋文忠,等.尼莫地平对脑出血患者局部脑血流、脑水肿及不同时间用药临床变化的影响[J].临床神经病学杂志,2001,14(1):6-9.

    [13]高山,孙华北,王秋生,等.银杏达莫注射液辅助颅内血肿清除术治疗高血压性脑出血的疗效观察[J].医学理论与实践,2015,28(17):2277-2279.

    [14]黄翔,兰周华,杨谦,等.银杏达莫对脑出血微创碎吸术后残余血肿及脑水肿的影响[J].齐齐哈尔医学院学报,2014,35(19):2879-2880.

    [15]崔玉国,荣阳,荣根满,等.高血压性脑出血的临床治疗与前瞻性研究[J].中国医药指南,2015,13(19):102-103.

    [16]Hu B L,Zou M,Chen S F,et al.Improvement of Xingnaojing onNeural Function in Acute Stage of Cerebral Hemorrhage and Effecton Serum Tf and Ft[J].Chin Arch TCM,2016,34(2):507-509.

    [17]Han S W,Zhao Y,Ren J X.Therapeutic Effect of UlinastatinCombined with Xingnaojing Injection for Acute CerebralHemorrhage[J].J Guangzhou Univ TCM,2015,32(1):19-22.

    [18]王引明,胡玲玲,孙钧铭,等.醒脑静对脑出血患者S100B、神经肽Y和脑水肿的影响[J].实用医学杂志,2011,27(8):1473-1475., 百拇医药(王希佳 李星 周子英 胡倩)
上一页1 2 3